• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS CHEMISTRY PRODUCTS VANC REAGENT; IN-VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS, INC. VITROS CHEMISTRY PRODUCTS VANC REAGENT; IN-VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6801709
Medical Device Problem Code Low Test Results (2458)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/29/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation determined that lower than expected vitros vancomycin (vanc) results were obtained from one level of a non vitros biorad quality control fluid and from two levels of vitros therapeutic drug monitoring (tdm) performance verifier (pv) fluids when using vitros vanc lot 2514-53-1873 on a vitros 5600 integrated system and a vitros 4600 chemistry system.The assignable cause of the event is related to the vitros vanc lot 2514-53-1873 reagent packs in use at the time of the event.The issue with the affected reagent packs is unknown.The customer confirmed that all of the affected packs were received from the same shipment on an unknown date.It is possible that an unknown storage issue occurred during and/or after the shipment of the vitros vanc packs and contributed to the event, however this could not be confirmed.The customer gave no indication of any issues with the refrigerator where the vitros vanc reagent packs were stored and did not indicate any issues from when the product was received.Per the vitros vanc instructions for use, only refrigerated storage is specified as acceptable.A systemic performance issue vitros vanc lot 2514-53-1873 did not likely contribute to the event as acceptable vitros vanc results were obtained both historically and after the event using alternate reagent packs of the same reagent lot.In addition, continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros vanc lot 2514-53-1873.A performance issue with the vitros 5600 integrated system or the vitros 4600 chemistry system did not likely contribute to the event, as acceptable results were obtained with alternate reagent packs with no actions performed on either analyzer.
 
Event or Problem Description
A customer contacted the ortho clinical diagnostics (ortho) technical solution center (tsc) to report lower than expected vitros vancomycin (vanc) results were obtained from one level of a non vitros biorad quality control fluid and from two levels of vitros therapeutic drug monitoring (tdm) performance verifier (pv) fluids when using vitros vanc lot 2514-53-1873 on a vitros 5600 integrated system and a vitros 4600 chemistry system.56002673: biorad level 2 lot 92962 results of <5.0, <5.0 and <5.0 versus the expected result of 33.499 ug/ml vitros tdm pvii lot a1735 results of <5.0, <5.0, <5.0 and <5.0 versus the expected result of 20.9 ug/ml vitros tdm pviii lot x1172 results of <5.0, <5.0, <5.0 and <5.0 versus the expected result of 41.5 ug/ml 46000263: biorad level 2 lot 92962 result <5.0 versus the expected result of 33.499 ug/ml biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The lower than expected results occurred on quality control fluids.No new patient samples were processed, as vanc quality control results were low outside the established ranges.There was no allegation of patient harm as a result of this event.This report is number two of four mdrs for this event.Four 3500a forms are being submitted for this event as four devices were involved.This report corresponds to ortho clinical diagnostics inc (ortho) complaint numbers (b)(4) and reportability assessment (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS CHEMISTRY PRODUCTS VANC REAGENT
Common Device Name
IN-VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS, INC.
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO-CLINICAL DIAGNOSTICS, INC.
1000 lee road
rochester NY 14606
Manufacturer Contact
laurie o'riordan
1295 southwest 29th avenue
pompano beach, FL 33069
9549709500
MDR Report Key18998577
Report Number1319808-2024-00011
Device Sequence Number8204011
Product Code LEH
UDI-Device Identifier10758750006731
UDI-Public10758750006731
Combination Product (Y/N)N
Initial Reporter CountryCA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/26/2024
Device Catalogue Number6801709
Device Lot Number2514-53-1873
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/01/2024
Initial Report FDA Received Date03/28/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured07/26/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-